undamentalytics Newsletter
Sign in

Optimizerx Corp revenue

Optimizerx Corp's revenue was $109m in fiscal 2025, up 18.8% on the year before. Since fiscal 2010 ($71,065) it has grown at a compound 63.1% a year. Over the last twelve months it was $98.7m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue0125778122125436162729210999
Growth on the year before—+>999%+79.0%+135.3%+39.0%+11.0%+7.4%+56.5%+74.9%+16.0%+76.1%+41.5%+1.9%+14.5%+28.8%+18.8%—
Gross profit——233446121524363943597472
Gross margin——94.2%60.2%50.5%49.8%56.0%49.1%57.6%62.8%55.7%58.1%62.4%60.0%64.5%67.3%73.2%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Life Science Companies $109M 99.8% ▲ 27.8%
Other Revenue $215,000 0.2% ▼ 96.8%

From Optimizerx Corp's 10-K filed March 12, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Technology: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Optimizerx Corp $98.7m -5.8% 17.0%
Sophia Genetics SA $77.3m 18.6% —
Carecloud, Inc. $129m 15.1% 0.8%
American Well Corp $219m -19.0% -7.4%
Definitive Healthcare Corp. $233m -5.0% -0.8%
Health Catalyst, Inc. $292m -7.5% 0.9%

Compare with peers

Head to head: OPRX vs SOPHCCLD vs OPRXAMWL vs OPRX

More: Health Care Technology stocks compared, Health Care sector, rankings of US companies

Figures from Optimizerx Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Optimizerx Corp.